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Abstract
Objectives: Diabetes Mellitus (DM) is a global and progressive chronic medical condition with increasing prevalence and associ-
ated costs throughout the world. Psychological problems are common in people with DM and when they co-occur are associated 
with negative patient and societal outcomes. Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive 
Therapy (MBCT) were to be effective in treating a variety of psychological problems in various health conditions. Thus, using 
MBSR and MBCT in DM patients may help alleviate psychological problems of anxiety and depression and improve glycaemic 
control as a result. In this systematic review, we investigated the effectiveness of MBSR and MBCT in improving glycaemic 
control, anxiety and depression in adults with DM. 
Interventions: Randomised-Controlled Trials (RCTs) and Pilot Studies (RCPS) evaluated the effectiveness of MBSR or MBCT. 
Electronic searches were carried out of the following databases CINAHL, CENTRAL, EMBASE, MEDLINE, PsycINFO, 
PubMed, and ongoing clinical trials websites. 
Main outcomes: This research examined the effectiveness of MBSR and MBCT on depression, anxiety and glycaemic control 
in adults with T1DM or T2DM.
Results: Research evidence has shown that patients with mental illnesses such as schizophrenia and anxiety disorders have a 
higher risk of developing DM than the general population.  Explicitly, evidence indicates that the prevalence of psychological 
problems is much higher than in the general population and globally, with a two-fold increase in the prevalence of depression 
and anxiety in DM patients. 3 RCTs and 1 RCPS found a total of 365 participants. Narrative and data synthesis indicated sig-
nificant reduction in levels of anxiety and depression at short-term and long-term time points.  However, no significant effect on 
glycaemic control was established. MBSR and MBCT are feasible and efficacious methods for depression and anxiety treatment 
in adults with T1DM or T2DM.  
DOI: 10.29011/ 2574-7568. 000049
Introduction 
Psychological disorders found in diabetes vary from disease-
specific concerns to eating and anxiety disorders [1]. The presence 
of these co-morbidities impairs quality of life, cost of care, treatment 
adherence, glycaemic control and self-management [2]. Evidence 
indicates patients with these co-morbidities have increased disease 
burden, work disability, medical device(s) dependence and 
symptom severity compared to patients with only diabetes [3-5]. 
Historically, non-pharmacological interventions for the 
treatment of diabetes have tended to focus on lifestyle advice and 
patient education [6,7]. Over the last decade, there has been an 
adoption of holistic care models with emphasis on psychological 
care for DM patients [8]. Research has shown psychotherapeutic 
interventions have the ability to improve glycaemic control, reduce 
emotional distress and improve levels of anxiety and depression in 
DM patients [9]. 
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Mindfulness-Based Stress-Reduction (MBSR) and Mind-
fulness-Based Cognitive Therapy (MBCT) are two emerging 
therapies that could benefit DM patients. MBSR and MBCT are 
structured group programmes that use mindfulness meditative 
techniques drawn from Buddhist practices and attempt to cultivate 
mindfulness skills and attitudes in order to alleviate suffering [10]. 
Participants were asked to use a non-judgemental, committed and 
accepting attitude in order to develop skills and attitudes of focus-
ing, sustaining and switching attention, and accepting their present 
moment experience [11].
This research systematically examines the effectiveness of 
MBSR and MBCT on depression, anxiety and glycaemic control 
outcomes in adults with T1DM or T2DM.
Methods
Search Strategy
The search strategy involved examination of the databases 
MEDLINE (1946-2017), CINAHL, Web of Science, PsycINFO 
(1806-2017), EMBASE (1974-2017), CENTRAL and PubMed us-
ing keywords such as, “Mindfulness”, “Meditation”, “Diabetes”, 
“Mindfulness-based Stress-reduction”, “Mindfulness-based Cog-
nitive Therapy”, “Glycaemic control”, depression” and “Anxiety”. 
The title, index terms, abstract and keywords found in the results 
of this preliminary search were analysed. Differences in the use 
of terminologies and regional variations in spelling (British and 
American) as well as common abbreviations such as “MBSR”, 
“MBCT”, “DM”, “T1DM” and “T2DM” were accounted for. Trun-
cations, wildcards, proximity terms, Boolean phrases and MeSH 
terms were used as appropriate. Comprehensive search filters were 
developed for each database including researched search strategies 
for finding RCTs and RCPS on the searched databases. 
Selection of Studies
This review considered only RCTs and RCPS. Both male 
and female participants; Aged 18 - 80 years; Diabetes (type 1 or 
type 2); Elevated levels of depressive symptoms and/or diabetes-
related distress; Low levels of emotional well-being. Studies on 
participants with acute psychosis or intention to commit suicide 
were excluded; severe physical co-morbidity (i.e., severe forms of 
cancer or heart failure); patients not experiencing psychological 
symptoms; unstable treatment with an antidepressant. The assess-
ment of glycosylated haemoglobin (HbA1c) was carried out in all 
studies.
Methodological Quality
The Cochrane Collaboration’s tool for assessing risk of bias 
was used to assess the methodological quality of included studies. 
To reduce the risk of bias a minimum of two independent review-
ers (JM/GGA) were used to perform selection of studies, data ex-
traction and methodological assessment.
Data Extraction
Data extraction was performed by reviewers (JM/GA) using 
the ‘Cochrane collaboration data collection form for intervention 
reviews: RCTs only’. The data extracted in this form was categor-
ised into methods, participants, intervention groups, outcomes, 
data and analysis, and other information. 
Excluded Studies
23 studies were excluded after detailed evaluation of the full 
text. The reasons for exclusion were: Non-RCT or RCPS (n=4), 
Non-MBSR or MBCT intervention (n=14), Non-MBSR or MBCT 
for DM (n=1), On-going trials (n=2), study did not include any rel-
evant outcomes (n=1) and study written in non-English language 
and unable to translate (n=1). 
Results
Risk of Bias in Included Studies
Methodologically sound studies were categorised as those 
with ≥ 5 low risk scores on the risk of bias summary, achieved by 
the Tovote and DIAMIND studies. 
Allocation concealment was considered low risk in only the 
Tovote study, which used measures to conceal allocation to both 
participants and investigators. The HEIDIS and DIAMIND studies 
did not give sufficient information on how allocation took place to 
make a judgement. The Schroevers study was deemed to be high 
risk as allocation concealment was not ensured.
Only Tovote’s study ensured blinding of participants but was 
unclear if there was any blinding of personnel. The other three 
studies were carried out as open-label trials.
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Figure 1: Flow diagram representing studies for inclusion.
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The three studies that used glycaemic control as an outcome 
were judged to be at low risk of bias as all used HbA1c as an 
objective measure. The outcomes that measured depression and 
anxiety using self-reporting mechanisms were judged at low risk 
only in Tovote’s study as this was the only study that blinded 
participants, the outcome assessors. In the three other studies, 
participants were not blinded and thus risk of bias was high. Only 
Tovote’s study used a non-self-reported depression and anxiety 
outcome, rated as high risk of bias as there was no blinding at of 
the assessor at post-intervention assessment.
Intention-to-treat analysis was conducted in all four studies 
with missing values estimated by means of multiple imputations 
using the linear regression method in three studies and Schroevers 
study using the last-observed response carried forward method 
for imputation of the missing values. Risk of bias for incomplete 
outcome data was judged to be low risk for all four studies as these 
were considered appropriate methods for imputing missing data 
and reasons for attrition were documented in all studies.
Selective outcome reporting is a legitimate concern with 
RCTs, with a particular concern that non-significant results be 
withheld from publication (Hutton and Williamson, 2000). The 
DIAMIND and Tovote studies were classified as low risk of bias for 
outcome reporting as both have protocols available and reported all 
the pre-specified outcomes as detailed in their protocols. Both the 
HEIDIS and Schroevers studies do not have a protocol available 
and were, therefore, judged to have a high risk of bias.
A total of 2048 studies were identified from the database 
search and 21 studies were identified from additional sources 
such as trial registry websites, references of relevant articles 
and searches of generic internet search engines. All studies were 
imported into EndNote X7, after which 748 duplicates were 
removed. After examining the titles and abstract, a further 1321 
studies were excluded, because the subject matter was not relevant 
to the review. The remaining 27 studies were then retrieved and 
full text evaluation against the inclusion and exclusion criteria 
took place, leading to the exclusion of 23 studies. Three RCTs and 
1 RCPS met the inclusion criteria and were included in the data 
synthesis. Figure 1 illustrates the study identification process.
Characteristics of Included Studies
Characteristics of included studies and participants have 
been summarised in Tables 1a, b, c. The RCPS (Schroever’s) was 
a pilot for the Tovote study, which is also included. This decision 
was made to include both separately as the RCPS met all the 
inclusion criteria and was sufficiently different from the Tovote 
study to merit inclusion. There was no risk of cross-contamination 
in participants, as the exclusion criteria for Tovote’s study would 
rule out all participants of Schroever’s study. Waiting-list control 
groups were used for comparison in three studies, of which the 
Tovote study also compared with a CBT group. The HEIDIS 
study used a treatment-as-usual control group for comparison. 
The waiting-list control group is a common feature of trials on 
psychotherapeutic interventions due to being more ethically sound 
as it allows for the provision of care, although delayed, to all 
participants needing help whilst still permitting a non-intervention 
evaluation.  
Sample sizes ranged from 24 to 139 with a median of 
92 participants. All studies used a face-to-face format for the 
interventions. Three studies used an adapted form of MBCT. Two 
of these were in groups while the Tovote study used an individual 
format. The HEIDIS study used an adapted form of MBSR in a 
group format.
All four studies examined depression as an outcome while 
three examined glycaemic control and two examined anxiety. The 
HEIDIS and Schroevers studies both used specified individual 
healthcare settings whereas the DIAMIND and Tovote studies both 
used multi-centre approaches in unspecified healthcare settings 
across the Netherlands.
No. Study Design
Types of 
Compari-
son
Country Interven-tion
Format of 
Interven-
tion
Sample 
Size (Total 
no. ran-
domized)
Outcomes 
of interest Setting
Duration 
(Start of 
Interven-
tion to last 
follow-up)
1
DIAMIND 
(van Son, et al., 
2011/2013/2014)
RCT
waiting-list 
control 
group
Nether-
lands
MBCT 
(Adapted)
Face-to-
face Group 139
Glycaemic 
Control, 
Anxiety 
Depression
Diabetes 
Outpatient 
Clinics 
across the 
Nether-
lands (not 
specified)
8 months
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2
HEIDIS (Hart-
mann et al., 2012; 
Kopf, et al., 2014)
RCT
treatment-
as-usual 
control 
group
Germany MBSR (Adapted)
Face-to-
face Group 110
Depres-
sion, 
Glycaemic 
Control
Diabetes 
Outpatient 
Clinic at 
the Uni-
versity of 
Heidelberg
3 years
3 Schroevers, et al. (2013) RCPS
waiting-list 
control 
group
Nether-
lands
MBCT 
(Adapted)
Face-
to-face 
Individual
24 Depression
Univer-
sity of 
Groningen 
Medical 
Center
3 months
4 Tovote et al., (2013/2014/2015) RCT
CBT and 
waiting-list 
control 
group
Nether-
lands
MBCT 
(Adapted)
Face-
to-face 
Individual
94
Depres-
sion, 
Anxiety, 
Glycaemic 
Control
Various 
hospitals 
across the 
Nether-
lands (not 
specified)
11 months
Table 1a: Characteristics of Included Studies.
Characteristics of Participants
The total number of participants in the four included studies was 367. The respective dropout rates of each study were: 33 of 139 
or 23.7% (DIAMIND), 21 of 110 or 19.1% (HEIDIS), 2 of 23 or 8.3%) (Schroevers) and 24 of 94 or 25.5% (Tovote).
The mean age of participants ranged from 49.8±13.3 years and 59.3±7.8 years. All studies included both genders with the range 
of male participants varying from 47% to 80.7%. The mean duration of DM was 11.0±7.5 years to 20.5±13.7; the DIAMIND study did 
not report this data (Table 1b).
The Percentage of T2DM participants varied from 42% to 74% in the three studies that included both T1DM and T2DM participants. 
The criteria that featured in all four studies, were the inclusion criteria of adults aged between 30 and 70 with T2DM and the exclusion 
criteria of serious psychopathology. 
The Schroevers and Tovote studies used a depression score above a specified cut-off point for validated scales as an inclusion 
criterion. Otherwise no cut-off was specified for a depression score and no studies featured cut-off scores for anxiety or HbA1c (Table 1c).
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Table 1b: Characteristics of Participants
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No. Study
Mean baseline for 
glycosylated haemoglobin (%)
Mean baseline score for depression 
(Study cut off)
Mean baseline score for 
Anxiety (Study cut off)
IG CG Study 
cut off
IG CG Study cut 
off
IG CG Study 
Cut off
1 DIAMIND  
(van Son, et al., 
2011/2013/2014) 
[12] 
7.5± 1 7.6± 1 Not Stated
HAD: 
7.9±3.8
HAD: 
8.9±3.9
Not stated
HAD: 
8.4±3.3
HAD: 
9.2±3.6
Not 
stated
 POMS: 25.3±5.8
POMS: 
26.6±6.3
POMS: 
20.3±4.5
POMS: 
20.1±4.4
2 HEIDIS (Hartmann 
et al., 2012 [13]
7.26± 
1.08 
7.27± 
1.06
Not 
Stated
PHQ-9 
depression: 
6.4± 4.9
PHQ-9 
depression: 
5.7± 4.3
Not stated Not Stated
3 Schroevers, et al. 
(2013) [14]
8.2±1.2 8.1±1.5 Not Stated
CES-D: 
22.9±8.0
CES-D: 
20.2±8.7 ≥16
Not 
Stated   
4
Tovote et al., 
(2013/2014/2015) 
[15]
MBCT: 
8.0±0.9 
CBT: 
8.3±1.4
None 
Stated
Not 
Stated
BDI-II 
MBCT: 
23.6±7.7 
CBT:  
25.6±8.7
BDI-II 
24.3±8.0
BDI-II 
score ≥ 14 
HAM: Not 
stated
GAD-7 
MBCT: 
12.6±5.3 
CBT: 
11.9±4.9
GAD-7 
9.8±5.0
Not 
StatedHAM-D7 
MBCT: 
8.9±3.5 
CBT: 
9.4±3.8
HAM-D7 
7.5±2.8
Table 1c: Characteristics of Participants.
Description of Interventions
The interventions varied in terms of format, difference to traditional MBSR or MBCT and duration of sessions. There were 
also commonalities in terms of the professional background of therapists, frequency of sessions and adherence of course structure to 
traditional MBSR or MBCT. The characteristics of the interventions in the four studies are detailed in Table 2.
In all four studies psychologists were used as therapists. This was either alone (DIAMIND and Schroevers), alongside a resident 
of internal medicine (HEIDIS) or with a diabetes nurse (Tovote). In all studies therapists had previous experience and training in MBSR 
or MBCT, with specialist training in the adapted intervention given prior to the intervention starting in three of the studies. 
Checklists were used in all three studies by participants and therapists to determine attendance and adherence to the intervention 
protocol and homework. The Tovote study used two independent observers who watched videotapes of each session and rated therapist 
adherence to the protocol. The HEIDIS study did not provide information on any measures to ensure treatment adherence. Post-
intervention adherence to mindfulness practice was not recorded in any of the studies.
# Study MBSR or MBCT
Regimen and 
Nature of 
MBSR/MBCT 
in Intervention 
Group
Therapist 
(training)
Differences 
to traditional 
MBSR or 
MBCT
Regimen 
in control 
group
Measures to 
maintain control 
group
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1
DIAMIND
 (van Son, 
et al., 
2011/2013
/2014)
MBCT
8 weekly 2 hour 
long face-to-face 
group sessions 
of 4 to 10 
participants.
Psychologist 
(4 years 
experience of 
Mindfulness 
practice and 
one certified 
mindfulness 
instructors 
training of 8 
days)
No Preclass 
participant 
interview. No 
Silent Day               
Session 1 - a 
discussion about 
the relationship 
between 
diabetes, diabetes 
management, 
diabetes 
outcomes and 
emotional 
distress             
Homework 5 
days a week 
instead of 6
Wait-list 
control 
group. 
Treatment as 
usual.
Not specified
Homework of 30 
minutes length 
for 5 days a 
week
2 hour booster 
session three 
months after end 
of intervention
Total Time 
(Excluding 
homework):18 
hours Total 
Time (including 
homework): 38 
hours
2
HEIDIS
 (Hartmann 
et al., 
2012; Kopf,
 et al., 2014)
MBSR
8 weekly face-
to-face group 
sessions of 6-10 
participants 
(length of 
sessions not 
stated but 
traditional 
MBSR is 2.5 
-3.5 hours) Psychologist 
(formal 
training in 
MBSR) and 
a resident 
in internal 
medicine
Included 
practices 
for difficult 
thoughts and 
feelings related 
to diabetes (no 
other information 
given)                     
Silent retreat day 
not mentioned
Treatment-
as-usual
All patients seen 
by a resident in 
internal medicine 
in the outpatient 
clinic before 
intervention, 
after 10 weeks 
and then yearly. 
Additionally, 
both groups were 
routinely seen by 
their diabetologist 
every 3-4 month 
on top of the study 
visit. All treatment 
recommendations 
were based on 
national diabetes-
guidelines. 
Homework not 
stated (if follows 
traditional 
MBSR would be 
50-60 minutes 6 
days a week)
Booster session 
after 6 months 
(duration not 
stated)
Unable to 
determine total 
time
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3 Schroevers, et al. (2013) MBCT
8 weekly 60 
minute long 
face-to-face 
individual 
sessions.
Psychologist
 (degree
 in clinical 
psychology, 
experience 
in delivering 
psychological 
treatment 
e MBCT
 group
 program
. Received
 3-days
 training in 
I-MBCT
 by an
 exper
ienced
 qualified 
mindfulness 
therapist)
No Preclass 
participant 
interview.  No 
Silent Day 
Individual rather 
than Group 
format 60 minute 
sessions rather 
than 120-150 
minute sessions 
Duration of 
exercises 
shortened in 
sessions Session 
2 - Cognitive 
exercise removed 
Sessions 4 and 
5 - psycho-
educational 
component was 
focused on a 
broader range 
of stress- and 
depression-
related 
symptoms, rather 
than specific 
depression 
symptoms 
Session 
7 - relapse 
prevention 
removed Instead 
of watching the 
video “Healing 
from within,” we 
introduced the 
reaction-response 
model from 
MBSR
Wait-list Not stated
Homework of 30 
minutes length 
for 6 days a 
week
Total Time 
(Excluding 
homework):8 
hours
Total Time 
(including 
homework): 32 
hours
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4 Tovote et al., (2013/2014/2015) MBCT
MBCT and 
CBT: 8 weekly 
45-60 minute 
long face-to-
face individual 
sessions MBCT and 
CBT: Trained 
Therapists, 
one a diabetes 
nurse who is 
a qualified 
mindfulness 
therapist, all 
other therapists 
have a master’s 
degree in 
clinical 
psychology 
and most of 
them have 
experience 
with diabetes 
patients. All 
therapists have 
experience in 
the delivery 
of the specific 
treatment 
(therapists 
receive an 
additional 
three day 
training by an 
experienced, 
qualified 
MBCT or CBT 
therapist who 
also provides 
supervision 
every three 
weeks 
throughout the 
intervention 
and study 
period.)
No Preclass 
participant 
interview. No 
Silent Day. 
Individual 
rather than 
Group format. 
60 minute 
sessions rather 
than 120-150 
minute sessions. 
Duration of 
exercises 
shortened in 
sessions. Session 
2 -Cognitive 
exercise 
removed. 
Sessions 4 and 
5 - psycho-
educational 
component was 
focused on a 
broader range 
of stress- and 
depression-
related 
symptoms, rather 
than specific 
depression 
symptoms. 
Session 
7 - relapse 
prevention 
removed Instead 
of watching the 
video “Healing 
from within,” we 
introduced the 
reaction-response 
model from 
MBSR 
Wait-list 
control Not stated
Homework of 30 
minutes length 
for 6 days a 
week
Total Time 
(Excluding 
homework):8 
hours
Total Time 
(including 
homework): 32 
hours 
CBT:
Treatment 
protocol based 
on CBT for 
depression 
developed by 
Beck et al. 
(1979). The first 
part of treatment 
is devoted to 
behavioural 
components of 
CBT. Second 
part of the 
treatment 
focuses on 
dysfunctional 
thinking patterns, 
allowing patients 
to recognize, 
challenge, 
and adjust 
their negative 
automatic 
thoughts.
Table 2: Characteristics of Interventions.
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Outcome Measures of Included Studies
With the exception of HbA1c, which was a requirement for inclusion in the review, no other measures were the same across the 
studies.
Time points measured for the outcomes varied but all studies measured results at baseline and post-intervention in all reported 
outcomes.
Therefore, the values shown (Table 3) represent a much larger time period either side of the intervention in comparison to the HEIDIS 
study which arranged for blood samples to be taken on a specified measuring. In the DIAMIND study, post-intervention HbA1c results 
can be from before the intervention has even finished.
The reliability of the psychometric tests used were good (Cronbach α=0.75-0.88) across the self-reported measures. The lowest Cronbach 
α (0.65) was for the HAM-D7, the only non-participant assessed psychometric measure.
# Study Outcomes Measures Scale Reliability Time points measured
Method of measuring/
reporting
1
DIAMIND 
(van Son, et al., 
2011/2013/2014)
Glycaemic Control: 
HbA1c Percentage (%)  
Pre-intervention - 
between 24 weeks 
before and 1 week 
after the start of the 
intervention 
Post-intervention  - 
between 6 and 24 
weeks after the 
intervention) 
6-month Follow-up
Retrieved from 
hospitals’ computerised 
patient records. 
Not stated who did this.
Depression: Hospital 
Anxiety and 
Depression Scale 
(HADS) Profile of 
Mood States (POMS)
HADS: 0-21 
0-7 = Normal 
8-10 = Borderline 
abnormal 
11-21 = Abnormal 
POMS=0-60
HADS: 
Cronbach α = 
0.81. POMS: 
Cronbach α = 
0.77-0.93
T1 - Baseline 
T2 - 4 weeks 
T3 - 8 weeks 
6-months Follow-up
Self-report by 
participants
Anxiety: Hospital 
Anxiety and 
Depression Scale 
(HADS)
HADS:0-21 
0-7 = Normal 
8-10 = Borderline 
abnormal 
11-21 = Abnormal 
POMS=0-36
HADS: 
Cronbach α = 
0.75 
POMS: 
Cronbach α = 
0.77-0.93
T1 - Baseline 
T2 - 4 weeks 
T3 - 8 weeks 
6-months Follow-up
Self-report by 
participants
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2
HEIDIS (Hartmann 
et al., 2012; Kopf, et 
al., 2014)
Glycaemic Control: 
HbA1c Percentage (%)  
Baseline 
Post-intervention - 10 
weeks 
1 year  follow-up 
2 years follow-up 
3 years follow-up
Blood samples were 
taken on the day of 
the respective visit in 
fasting state. 
Not stated who did this.
Depression: Patient 
Health Questionnaire - 
9 (PHQ-9)
0-27 Not Stated
Baseline 
Post-intervention - 10 
weeks 
1 year follow -up
Self-report by 
participants
Anxiety: Not stated     
3 Schroevers, et al. (2013)
Glycaemic Control: 
Not stated     
Depression: Center for 
Epidemiology Studies 
Depression Scale 
(CES-D)
0-60 (20 questions, 
scored 0-3) 
≥16 is used to 
define patients at 
risk for a clinical 
depression.
Cronbach 
α=0.85
T1 - 2-3 weeks before 
start of intervention 
T2 - Within 2 weeks of 
finishing intervention 
(8-10 weeks from start) 
T3 - 3 months after 
finishing intervention
Self-report by 
participants
Anxiety: Not stated     
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4 Tovote et al., (2013/2014/2015)
Glycaemic Control: 
HbA1c Percentage (%)  
Pre-treatment - average 
of all assembled values 
of 0-6 months prior to 
the intervention. 
Post-treatment - 
average of all values 
between 1 and 6 
months after the 
Intervention. 
9- month Follow-
up - average of all 
values between 6 and 
12 months after the 
intervention.
From Patients’ Records 
 
Not stated who did this.
Depression: Beck 
Depression Inventory-
II (BDI-II) 
 
Toronto Hamilton 
Depression Rating 
Scale (HAM-D7)
BDI-II: 0-63 (21-
item questionnaire 
each scored 0-3) 
14-19 indicates 
mild depression  
20-28 moderate 
depression,  
≥29 indicates 
severe depression 
HAM-D7: 0-26 
(7-item semi 
structured clinical 
interview) 
≥4 mild depression, 
12-20 moderate 
depression 
>20 severe 
depression
BDI-II: 
Cronbach α = 
0.84 
 
HAM-D7: 
Cronbach α = 
0.65
Premeasurement 
 
After Treatment (8 
weeks) 
 
3-month Follow-up 
 
9-month Follow-up 
(BDI-II only)
BDI-II: Self-reported 
by participants 
 
HAM-D7: trained 
psychologists 
 
Blinded at pre-
measurement 
 
Not blinded at post-
measurement
Anxiety: Generalized 
Anxiety Disorder 7 
(GAD-7)
0-21 (7-item self-
report instrument, 
each scored 0 to 3) 
 
A total sum score 
of ≥5 indicates 
mild anxiety, a 
score of 11-15 
moderate anxiety, 
and a score of >15 
indicates severe 
anxiety
Cronbach α = 
0.88
Premeasurement 
 
After Treatment (8 
weeks) 
 
3-month Follow-up 
 
9-month Follow-up
Self-reported by 
participants
Table 3: Outcome Measures of Included Studies.
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Study Results and Data Synthesis
For this synthesis an effect size (Cohen’s d) of >0.8 was considered large, <0.8 and >0.5 was medium and <0.5 was small. The P 
value significance level was 0.05.
Glycosylated Haemoglobin
Glycosylated haemoglobin was reported as an outcome in 3 of the 4 included studies, all of which were RCTs. The results are 
shown in Table 4a. The results were organised into short-term (post-intervention, up to 6 months) and long-term (between 6 months 
and 1 year) in order to allow for comparison. The results in all three studies show a statistically and clinically insignificant effect on 
glycosylated haemoglobin at both short-term and long-term time points. In all measures reported (mean HbA1c, P, d) the results indicate 
no significant effect of MBSR or MBCT on HbA1c.
The average change in mean HbA1c across all of the MBSR and MBCT groups was -0.04% at both long-term and short-term 
time points, a clinically insignificant change. Effect sizes and in all studies and at all time points remained small as, with the exception 
of the HEIDIS study, all effect sizes remained ≤0.15. P values also reflected this with no statistically significant values reported (P 
value=<0.05). The HEIDIS study also reported HbA1C time points at 2 and 3 years. While effect sizes did increase from the 1-year 
follow-up onwards and mean HbA1c levels improved in the intervention group in comparison to the control group, the size of this effect 
remained small (d<0.5). 
Study
Mean 
HbA1c 
Baseline 
(SD)
Mean 
HbA1c 
Short-
term 
(SD)
Absolute 
Difference 
(to 
baseline)
P value
Mean 
HbA1c 
Long-
term 
(SD)
Absolute 
Difference 
(to 
baseline)
P 
value
Effect 
Size 
(Cohen 
d) 
Baseline 
to Short-
term vs. 
CG (95% 
CI)
Effect Size 
(Cohen d) 
Baseline to 
Long-term 
vs. CG 
(95% CI)
DIAMIND 
(van Son, et al., 
2011/2013/2014)
IG 7.5 (1.2) 7.5 (1.1) 0 0.37 7.6 (1.1) 0.1 0.816
0.14  
(0.06-
0.23)
0.06 (not 
stated)
CG 7.6 (1.2) 7.8 (1.5) 0.2  7.7 (1.5) 0.1    
HEIDIS 
(Hartmann et al., 
2012; Kopf, et al., 
2014)
IG 7.26 (1.08)
7.2 
(0.73) -0.06 0.7015
7.2 
(1.02) -0.06 0.151
0.09 (not 
stated)
0.37 (not 
stated)
CG 7.27 (1.06)
7.1 
(0.83) -0.17  
7.5 
(1.21) 0.23    
Tovote et al., 
(2013/2014/2015)
MBCT 8.0 (0.9) 7.9 (1.0) -0.1 0.92 7.7 (0.9) -0.3 0.53 0.03
0.10 (-0.31 
to 0.51) (not 
vs. CG)
CBT 8.3 (1.4) 8.2 (1.2) -0.1 0.72 7.9 (1.0) -0.4 0.38 0.08
0.15 (-0.27 
to 0.56) (not 
vs. CG)
◊◊◊ = Large Positive Effect (d and CI >0.80) ◊◊ = Medium Positive Effect (d>0.80 and if stated CI ≤0.80) ◊= Small Positive Effect (d and if stated 
CI = >0.50 and ≤0.80
Table 4a: Glycosylated Haemoglobin Outcomes of Included Studies.
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Depression
Depression was reported as an outcome in all four included studies. Scores were organised into baseline, short-term (post-
intervention up-to 3 months) and long-term (6 months to 1-year post-intervention) as these reflected the common results reported in the 
studies. The results of the findings in the studies are displayed in Table 4b. All reductions in scores indicated an improvement in levels 
of depression. All studies found reductions in levels of depression at both short-term and long-term time points in comparison to the 
baseline. 
The short-term results showed a significant positive effect on levels of depression compared with the control groups 
in the DIAMIND study (P=<0.01 and <0.001), the Schroevers study (P=0.002) and the Tovote study (P=<0.001). The 
effect sizes (Figure 1) for these results were medium in both the DIAMIND study outcome measures (d= 0.59, 0.71). 
Otherwise the effect sizes were large with the Tovote and Schroevers studies finding effect sizes over 1 for the CES-D and 
HAM-D7 outcome measures. The HEIDIS study, which was the only study to use MBSR, was the only study in the short-
term to find an insignificant positive effect on levels of depression compared with a control group (P= 0.9090, d=0.03).
The results for long-term effects of MBSR or MBCT on levels of depression were varied and only reported in 3 studies. All results 
remained statistically significant (P value <0.05) but effect sizes (Figure 1) reduced in all studies except HEIDIS. Effect sizes were 
small in the POMS DIAMIND outcome (d=0.48) and medium in all other outcome measures (d=0.51 - 0.77). The HEIDIS study saw 
a dramatic improvement in the effect size (d=0.03 to 0.71) and P value (P=0.9090 to 0.007). However, the reduction in the depression 
score (PHQ-9) was relatively small while the control group scores increased, indicating the intervention was effective in preventing 
progression in the long-term rather than a true reduction in depression.
Long-term follow-up results also increased in comparison with the short-term results in two studies. 
Study  Baseline (SD)
Short-
term
Absolute 
Difference 
(to 
baseline)
P value Long-term
Absolute 
Difference 
(to 
baseline)
P value
Effect 
size (d)  
Baseline - 
Short-term 
vs. CG 
(95% CI)
Effect 
size (d)  
Baseline 
- Long-
term vs. 
CG (95% 
CI)
DIAMIND 
(van Son, et al., 
2011/2013/2014)
HADS: 
IG 7.9 (3.8) 5.3 (4.1) -2.6 <0.01 5.2 (3.6) -2.7 0.004
0.59 (0.56-
0.61)◊
0.51 (not 
stated)◊
HADS: 
CG 8.9 (3.9) 8.5 (4.7) -0.4  8.2 (4.5) -0.7    
POMS: 
IG
25.3 
(5.8)
21.6 
(4.5) -3.7 <0.001
21.8 
(4.7) -3.5 0.016
0.71 (0.68-
0.75)◊
0.48 (not 
stated)
POMS: 
CG
26.6 
(6.3)
26.2 
(7.0) -0.4  
25.7 
(7.3) -0.9    
HEIDIS 
(Hartmann et al., 
2012; 
PHQ-9: 
IG 6.4 (4.9) 5.7(3.9) -0.7 0.909 5.3 (3.5) -1.1 0.007
0.03  (not 
stated) 0.71◊
PHQ-9: 
CG 5.7 (4.3) 5.8 (4.4) 0.1  7.3 (4.2) 0.1    
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Schroevers, et al. 
-2013
CES-D: 
IG
22.9 
(8.0)
14.4 
(7.5) -8.5 0.002 No data No data No data
1.23 (not 
stated)◊◊
No data
CES-D: 
CG
20.2 
(8.7)
23.6 
(7.4) 3.4  No data No data No data  No data
Tovote et al., 
(2013/2014/2015)
BDI-II: 
MBCT
24.2 
(8.3)
15.9 
(11.9) -8.3 <0.001
16.8 
(10.8) -7.4 <0.001
0.80 (0.27-
1.31)◊
0.77 
(0.34 - 
1.19) (not 
vs. CG)◊
BDI-II: 
CBT
25.6 
(8.7)
17.4 
(11.9) -8.2 <0.001
18.7 
(10.8) -6.9 <0.001
1.00 (0.47-
1.51)◊◊
0.62 
(0.19 - 
1.04) (not 
vs. CG)◊
BDI-II: 
CG
24.3 
(8.0)
23.5 
(10.3) -0.8 0.52 No data No data No data  No data
HAM-
D7: 
MBCT
8.9 (3.5) 4.7 (4.3) -4.2 <0.001 No data No data No data 1.17 (0.61-
1.69)◊◊
No data
HAM-
D7: 
CBT
9.4 (3.8) 4.6 (3.4) -4.8 <0.001 No data No data No data 1.09 (0.55-
1.60)◊◊
No data
HAM-
D7: CG 7.5 (2.8) 7.1 (3.7) -0.4 0.49 No data No data No data  No data
◊◊◊ = Large Positive Effect (d and CI >0.80) ◊◊ = Medium Positive Effect (d>0.80 and if stated CI ≤0.80) ◊= Small Positive Effect (d and if 
stated CI = >0.50 and ≤0.80
Table 4b: Depression Outcomes of Included Studies.
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Anxiety
Two of the four studies examined the effect of MBSR or MBCT on anxiety, both of which were RCTs. Table 4c represents the data 
for anxiety outcomes in these studies. All reductions in scores indicated an improvement in levels of anxiety.
Changes in the mean scores of the three anxiety outcome measures illustrate that in all MBCT or MBSR intervention groups, 
scores for anxiety reduced compared to baseline by at least 3 times more than the control groups at both short-term and long-term time 
points. Reduced anxiety scores remained consistent at the long-term follow-up time point measured.
P values corroborated the reductions in anxiety scores as all were statistically significant. 
Figure 2 illustrates the effect sizes reported in the studies. Effect sizes for MBSR or MBCT intervention groups compared 
to control groups were large (data not shown), with a small effect (d=0.44). At the 6-month follow-up in the DIAMIND study 
both the HADS and POMS outcome measures had a large effect size as both anxiety scores continued to reduce in the interven-
tion groups. Tovote reported the same medium effect size (d = 0.78) for both MBCT and CBT in comparison to the baseline scores.
Figure 2: Effect studies reported in studies
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Study  Baseline (SD) 4 weeks 8 weeks
Absolute 
Difference 
(8 weeks to 
baseline)
P 
value
6-month 
FU
Absolute 
Difference 
(6-month 
FU to 
baseline)
P 
value
Effect 
Size 
(Cohen 
d) 
Baseline 
8 weeks 
vs. CG 
(95% 
CI)
Effect Size 
(Cohen d) 
Baseline to 
6-month 
FU vs. CG 
(95% CI)
DIAMIND 
(van Son, et al., 
2011/2013/2014)
HADS: 
IG 8.4 (3.3) 7.5 (4.1) 6.3 (3.5) -2.1 0.02 5.4 (3.1) -3 <0.001
0.44 
(0.42-
0.46)
0.83 (not 
stated)◊◊
HADS: 
CG 9.2 (3.6) 9.0 (3.7) 8.7 (4.1) -0.5  8.8 (3.9) -0.4    
POMS: 
IG 20.3 (4.5) 19.0 (5.2) 17.3 (4.1) -3 <0.001
16.4 
(3.4) -3.9 <0.001
0.82 
(0.80—
0.85)◊◊
0.92 (not 
stated)◊◊
POMS: 
CG 20.1 (4.4) 20.0 (4.6) 19.7 (5.1) -0.4  
19.4 
(5.0) -0.7    
Study  Baseline (SD)
After 
Treatment
3-month 
FU
Absolute 
Difference 
(3-month 
FU to 
baseline)
P 
value
9-month 
FU
Absolute 
Difference 
(9-month 
FU to 
baseline)
P 
value
Effect 
Size 
(Cohen 
d) 
Baseline 
8 weeks 
vs. CG 
(95% 
CI)
Effect Size 
(Cohen d) 
Baseline to 
0-month 
FU (95% 
CI)
Tovote et al., 
(2013/2014/2015)
GAD-7: 
MBCT 11.4 (5.5) 7.0 (4.5) 6.5 (4.9) -4.9 <0.001 7.2 (5.1) -4.2 <0.001
0.98 
(0.44-
1.49)◊◊
0.78 (0.36 - 
1.21)◊
 GAD-7: CBT 10.7 (5.0) 6.1 (4.6) 7.0 (4.4) -3.7 <0.001 7.2 (3.9) -3.5 <0.001
0.82 
(0.29-
1.32)◊◊
0.78 (0.35 - 
1.2)◊
 GAD-7: CG 9.8 (5.0) No data 8.2 (4.6) -1.6  No data     
◊◊◊ = Large Positive Effect (d and CI >0.80) ◊◊ = Medium Positive Effect (d>0.80 and if stated CI ≤0.80) ◊= Small Positive Effect (d and if stated CI = >0.50 
and ≤0.80
Table 4c: Anxiety Outcomes of Included Studies and absolute differences.
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Discussion
This research examined the effectiveness of MBSR and 
MBCT on depression, anxiety and glycaemic control in adults 
with T1DM or T2DM.
Depression
Three of the four included studies reported a significant 
reduction in levels of depression in comparison to control groups 
at short-term, with these levels either decreasing further or 
remaining stable at long-term measurements in all studies. In the 
one study that also compared to a CBT group, the reductions were 
of a similar value. The results of the four studies gave a promising 
indication that depression levels in DM patients were positively 
affected by MBSR and MBCT [16]. These preliminary findings 
on the research are, therefore, congruent with the results reported 
for the effectiveness of MBSR and MBCT in treating depression 
in other disorders [17]. However, definitive conclusions cannot 
be drawn based on the data in this review as there is insufficient 
evidence from the four studies and no meta-analysis (M-A) 
has been performed to combine the findings. Results were not 
uniformly of a large effect size and therefore must be treated with 
caution until more RCTs are performed and subsequent M-A can 
be done on enough studies to be meaningful.
The reduction in levels of depression could be attributed to 
the cultivation of increased awareness of one’s thoughts in order to 
be able to reappraise negative thoughts and experiences that are a 
feature of depression [18-19]. 
Anxiety
MBCT and MBSR reduced anxiety levels significantly more 
than control groups and slightly more than a CBT group at both 
short-term and long-term measurements. However, only two studies 
reported results for anxiety outcomes so, although the results were 
promising, they must be taken as inconclusive. While a M-A could 
theoretically be performed on these studies, the validity of results 
would be called into question so more research is needed from 
large-scale RCTs before any conclusive judgements can be made. 
Despite this, results were still in line with previous research that 
has indicated MBSR and MBCT are effective in reducing anxiety 
levels in the general population [20]. 
The reduction in anxiety levels of the participants in the two 
included studies could be attributed to the cultivation of skills to 
focus the mind and detach from one’s thoughts. In this way when 
anxiety arises participants are able to step-back and see anxiety as 
clearly an emotional state that may pass in time.
Glycaemic Control
MBSR and MBCT were found to have had no statistically 
or clinically significant effect on HbA1c levels in the short-term or 
long-term. There was no indication of a positive difference between 
MBSR and MBCT and control groups or CBT, with mean HbA1c 
levels remaining relatively consistent in all groups from baseline 
to up to 3 years. The results, while not conclusive, are important as 
they are in contrast to findings from smaller-scale non-randomised 
studies by [18-19]. Methodological flaws of measuring HbA1c in 
2 of the 3 RCTs in this review may partially explain the variance. 
Rather than arrange for blood tests at set time points during the 
studies, patient’s records were used resulting in non-specific 
HbA1c results. Glycaemic control was also not the primary focus 
of any of the included studies in this review, partially explaining 
the methodological flaws as studies sought to not overload 
participants with measurements. This contrasts with studies [21-
22] that specifically focussed on glycaemic control, measuring 
HbA1c at specific time points and using HbA1c parameters in 
the inclusion criteria in order to select poorly controlled diabetes 
patients. Despite this, these studies were small-scale and non-
randomised so the validity of their findings is still questionable.
Consequently, more research from large-scale RCTs 
that focus on glycaemic control as a primary outcome, target 
poorly controlled DM patients and use methodologically sound 
measurements of blood glucose levels are needed in order to make 
definitive conclusions.
Conclusion
The aim of this review was to evaluate the effectiveness of 
MBSR and MBCT on glycaemic control, anxiety and depression 
in adult Diabetes Mellitus (DM) patients. Three RCTs and one 
RCPS met the inclusion criteria and were included in the data 
synthesis. Findings of the included studies showed no significant 
effect of MBSR and MBCT on glycaemic control, but a significant 
reduction in depression and anxiety levels was established with 
effects consistent for up-to a year.
Based on these findings, it is strongly recommended that 
more large-scale methodologically sound RCTs are carried out on 
MBSR and MBCT in DM patients so that these positive trends 
for can be investigated further. Also, MBSR and MBCT can very 
tentatively be considered as a means for improving anxiety and 
depression in DM patients. However, these findings should be 
interpreted with caution as due to the limitations of the review, 
the high risk of bias, the paucity of relevant evidence found and 
the lack of any statistical analysis, this review does not have the 
power to make any significant conclusions. The findings however, 
are promising and certainly warrant further investigation. 
Funding: Funding was provided by the Independent Diabetes 
Trust (IDDT).
Duality of Interest: Gary G Adams is a Non-Executive 
Director of IDDT and accepts no remuneration. There was no input 
from IDDT in the study design or interpretation of results.
Citation: Mason J, Meal A, Shaw I, Adams GG (2018) Outcomes of Mindfulness-based Stress Reduction and Mindfulness-based Cognitive Therapy in Adults with dia-
betes: A Systematic Review. J Diabetes Treat: JDBT-149. DOI: 10.29011/ 2574-7568. 000049
20 Volume 2018; Issue 02
J Diabetes Treat, an open access journal
ISSN: 2574-7568
Conflicts of Interest: Authors declare no conflict of 
interest.
Contribution statement as per: All authors have made 
substantial contributions to the conception, design of the work and 
acquisition and analysis, of data for the work. All authors (JM, AM, 
IS and GGA) have contributed in drafting and revising the work. 
They have also had final approval of the version to be published 
and agree to be accountable for all aspects of the work in ensuring 
that questions related to the accuracy or integrity of any part.
References
Britneff E, Winkley K (2013) The role of psychological interventions for 1. 
people with diabetes and mental health issues. Journal of Diabetes 
Nursing 17: 305-310.
Strandberg R, Graue M, Wentzel-Larsen T, Peytor M, Rokne B (2014) 2. 
Relationships of diabetes-specific emotional distress, depression, 
anxiety, and overall well-being with HbA1c in adult persons with type 1 
diabetes. Journal of Psychosomatic Research 77: 174-179.
Ludman EJ, Katon W, Russo J, Von Korff M, Simon G, et al. (2004) 3. 
Depression and diabetes symptom burden. General Hospital Psychia-
try 26: 430-436.
Von Korff M, Katon W, Lin EH, Simon G, Ciechanowski P, et al. (2005) 4. 
Work disability among individuals with diabetes. Diabetes Care 28: 
1326-1332.
Ciechanowski PS, Katon WJ, Russo JE (2000) Depression and dia-5. 
betes: impact of depressive symptoms on adherence, function, and 
costs. Archives of Internal Medicine 160:  3278-3285.
International Diabetes Federation (IDF) (2012) Global Guideline for 6. 
Type 2 Diabetes. 
National Institute for Health and Care Excellence (NICE) (2014) Type 2 7. 
Diabetes: The management of type 2 diabetes NICE Guidelines [CG87]. 
American Diabetes Association (2015) Classification and Diagnosis of 8. 
Diabetes Mellitus. Diabetes Care 38: S8-S16.
van der Feltz-Cornelis CM, Nuyen J, Stoop C, Chan J, Jacobson AM, 9. 
et al. (2010) Effect of interventions for major depressive disorder and 
significant depressive symptoms in patients with diabetes mellitus: a 
systematic review and meta-analysis. General Hospital Psychiatry 32: 
380-395.
Cullen M (2011) Mindfulness-Based Interventions: An Emerging Phe-10. 
nomenon. Mindfulness 2: 186-193.
Shonin E, Van Gordon W, Griffiths MD (2013) Mindfulness-based in-11. 
terventions: towards mindful clinical integration. Frontiers in Psychol-
ogy 4: 194. 
van Son J, Nyklíček I, Pop VJ, Pouwer F (2011) Testing the effective-12. 
ness of a mindfulness-based intervention to reduce emotional distress 
in outpatients with diabetes (DiaMind): design of a randomized con-
trolled trial. BMC Public Health 11: 131.
Hartmann M, Kopf S, Kircher C, Faude-Lang V, Djuric Z, et al. (2012) 13. 
Sustained Effects of a Mindfulness-Based Stress-Reduction Interven-
tion in Type 2 Diabetes Patients Design and first results of a random-
ized controlled trial (the Heidelberger Diabetes and Stress-Study) Dia-
betes Care 35: 945-947.
Tovote KA, Fleer J, Snippe E, Bas IV, Links TP, et al. (2013) Cognitive 14. 
behavioral therapy and mindfulness-based cognitive therapy for de-
pressive symptoms in patients with diabetes: design of a randomized 
controlled trial. BMC Psychol 1: 17.
Tovote, KA, Fleer J, Snippe E, Peeters AC, Emmelkamp PM, et al. 15. 
(2014) Individual Mindfulness-Based Cognitive Therapy and Cognitive 
Behavior Therapy for Treating Depressive Symptoms in Patients With 
Diabetes: Results of a Randomized Controlled Trial Diabetes Care 37: 
2427-2434.
Kuyken W, Hayes R, Barrett B, Byng R, Dalgleish T, et al. (2015) Ef-16. 
fectiveness and cost-effectiveness of mindfulness-based cognitive 
therapy compared with maintenance antidepressant treatment in the 
prevention of depressive relapse or recurrence (PREVENT): a ran-
domised controlled trial. Lancet 386: 63-73.
Hofmann S, Sawyer A, Witt A, Oh D (2010) The effect of mindfulness-17. 
based therapy on anxiety and depression: A meta-analytic review. 
Journal of Consulting and Clinical Psychology 78: 169-183.
Janssen M, Heerkens Y, Kuijer W, van der Heijden B, Engels J (2018) 18. 
Effects of Mindfulness-Based Stress Reduction on employees’ mental 
health: A systematic review PLoS One 13.
Fortuna LR, Porche MV, Padilla A (2018) A treatment development 19. 
study of a cognitive and mindfulness-based therapy for adolescents 
with co-occurring post-traumatic stress and substance use disorder 
Psychol Psychother 91: 42-62.
Proeve M, Anton R, Kenny M (2018) Effects of mindfulness-based cog-20. 
nitive therapy on shame, self-compassion and psychological distress 
in anxious and depressed patients: A pilot study. Psychol Psychother.
Rosenzweig S1, Reibel DK, Greeson JM, Edman JS, Jasser SA, et 21. 
al. (2007) Mindfulness-based stress reduction is associated with im-
proved glycemic control in type 2 diabetes mellitus: a pilot study. Altern 
Ther Health Med: 36-38.
Whitebird RR, Kreitzer, MJ, O’Connor PJ (2009) Mindfulness-Based 22. 
Stress Reduction and Diabetes Diabetes Spectr 22: 226-230.
